Search

Novagali Pharma, accessing new eye therapies

Pipeline

You are here : Home > Eye Therapy > Pipeline

Novagali’s Product Portfolio

Fully integrated product development: from research to market authorization

Our pipeline includes products at various stage of development that address diseases of the three segments of the eye.

 

The following table summarizes the current development of our Ophthalmic Products
  Products Formulation Pre - clinical Phase 1 Phase 2 Phase 3 Registration Marketing
   
Surface
Novasorb®		 Cationorm®
MILD DRY EYE 		 X X X  X X X X X X X X X X  
Vekacia®
Cyclosporine A
VKC		 X X X X X X X X X X X      
Cyclokat®
Cyclosporine A
MODERATE TO SEVERE DRY EYE 		 X X X X X X X X X          
Nova21046
Imidazole
FUNGAL KERATITIS 		 X X X                      
NOVA21048
Antisense oligonucleotide
ALLERGY 		 X                          
Anterior
Segment
 Nova21027
Latanoprost
GLAUCOMA 		 X X X                      
Posterior
Segment
 Cortiject®
Corticosteroid
DIABETIC MACULAR EDEMA 		 X X X X X                  

Choose your language